Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

West Pharmaceutical Services, Inc. Appoints New Chief Financial Officer

By Pharmaceutical Processing | August 19, 2003

West Pharmaceutical Services, Inc. has announced the appointment of William J. Federici, 44, as the company’s Vice President and Chief Financial Officer, effective immediately.

Mr. Federici will have responsibility for the Company’s corporate finance and accounting functions. Mr. Federici joins West with more than twenty years of experience in public accounting for the pharmaceutical industry. Mr. Federici’s career began in 1982 at Arthur Anderson, where he progressed to Partner and served as that firm’s Worldwide Pharmaceutical Industry Leader. Most recently, Mr. Federici served as practice leader for the pharmaceuticals industry in the Americas and engagement partner for several pharmaceutical companies at KPMG LLP.

Donald E. Morel, Jr., Ph.D., West’s Chairman and Chief Executive Officer commented, “In addition to broad pharmaceutical industry experience, Mr. Federici brings extensive knowledge and expertise in financial statement assurance, business risk analysis, internal controls, SEC registration and reporting and acquisitions and divestitures. His background and financial and industry expertise make Mr. Federici a strong addition to our management team and he will play a critical role in West’s continued growth and financial performance.”

Mr. Federici holds a BA in Economics and an MBA in Professional Accounting from Rutgers University and is a Certified Public Accountant. Mr. Federici is also an Advisory Board Member of the Rutgers University School of Business; President of the Board of Trustees at Cancer Care of New Jersey; and, Member of the Editorial Board at the Journal of Generic Medicines.

Related Articles Read More >

This is a screenshot from a Varda Space Industries promotional video showing a space capsule with the company's logo docking onto a satellite.
Varda raises $187M Series C for drug manufacturing in space
This is the logo of Hikma.
Hikma to spend another $1B on US manufacturing, R&D
Great Point Partners logo.
Great Point Partners acquires majority stake in Eutecma to fuel sustainable cold chain growth
Driving success in fast-paced high-tech pharma construction projects
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE